C07D 487/18
Bridged systems
C07D487/18 (Bridged systems) appears on 243 US grants and 311 published applications in this corpus.
Search patents in C07D- Granted patents
- 243
- Published applications
- 311
- Assignees
- 181
- Inventors
- 1,004
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 2 | 0 |
| 1978 | 5 | 0 |
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 1 | 0 |
| 1985 | 3 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 2 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 4 | 0 |
| 1994 | 2 | 0 |
| 1995 | 2 | 0 |
| 1996 | 2 | 0 |
| 1997 | 4 | 0 |
| 1998 | 1 | 0 |
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 2 | 2 |
| 2003 | 1 | 1 |
| 2004 | 1 | 4 |
| 2005 | 3 | 9 |
| 2006 | 2 | 5 |
| 2007 | 3 | 1 |
| 2008 | 4 | 6 |
| 2009 | 3 | 4 |
| 2010 | 2 | 12 |
| 2011 | 2 | 10 |
| 2012 | 9 | 13 |
| 2013 | 11 | 15 |
| 2014 | 12 | 26 |
| 2015 | 20 | 23 |
| 2016 | 20 | 21 |
| 2017 | 18 | 14 |
| 2018 | 10 | 14 |
| 2019 | 15 | 16 |
| 2020 | 14 | 13 |
| 2021 | 12 | 15 |
| 2022 | 10 | 10 |
| 2023 | 10 | 18 |
| 2024 | 8 | 19 |
| 2025 | 9 | 28 |
| 2026 | 6 | 12 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Macrocyclic diamine derivatives as ENT inhibitors for the treatment of cancers, and combination thereof with adenosine receptor antagonists25 Aug 2026US 12,715,880 B2iTeos Belgium SA
- Indolo[3.2.1-jk]carbazole-6-carbonitrile derivatives as blue fluorescent emitters for use in OLEDS21 Jul 2026US 12,690,385 B2
- N-(pyridin-2-yl)-6,7,8,9-tetrahydro-5h-5,8-epiminocyclohepta[c]pyridine-10-carboxamide derivatives and similar compounds as GPR65 modulators for the treatment of cancer9 Jun 2026US 12,649,744 B2Pathios Therapeutics Limited
- Fused tricyclic derivative and pharmaceutical application thereof31 Mar 2026US 12,590,082 B2Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Uracil derivatives having virus replication inhibitory activity and pharmaceutical composition comprising the same10 Feb 2026US 12,545,687 B2Shionogi & Co., Ltd.
- Novel compounds and uses thereof13 Aug 2026US 2026/0234163 A1Acelink Therapeutics, Inc.
- Compounds that participate in cooperative binding and uses thereof6 Aug 2026US 2026/0224565 A1Revolution Medicines, Inc.
- Bifunctional selective degraders of smarca2 and therapeutic uses thereof23 Jul 2026US 2026/0209231 A1
- Benzimidazole derivatives for the modulation of sting23 Jul 2026US 2026/0209240 A1Aculeus Therapuetics Pty Ltd
- Fused tricyclic derivative and pharmaceutical application thereof16 Jul 2026US 2026/0200904 A1Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Most cited
By later US patents
- 2,4-disubstituted pyrimidines useful as kinase inhibitors178US 8,338,439 B2Celgene Avilomics Research, Inc. · 2012
- 2,4-disubstituted pyrimidines useful as kinase inhibitors115US 8,450,335 B2Celgene Avilomics Research, Inc. · 2013
- 2,4-diaminopyrimidines useful as kinase inhibitors69US 8,609,679 B2Celgene Avilomics Research, Inc. · 2013
- 2,4-disubstituted pyrimidines useful as kinase inhibitors54US 8,710,222 B2Celgene Avilomics Research, Inc. · 2014
- Phthalamide lanthanide complexes for use as luminescent markers48US 6,515,113 B2The Regents of the University of California · 2003